Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-10-20
    E.g., 2018-10-20

Archive Search

1 results
12:00 AM, May 16, 2016  |  BC Week In Review | Company News  |  Other News

Epirus biosimilars, hematology, cancer news

preclinical compounds BOW080 , a biosimilar of Soliris eculizumab, to treat ultra-rare blood disorders and BOW070